Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

AMAG Pharmaceuticals, Inc. (AMAG) Stock Forecast 2025 - AI Price Prediction & Analysis

AMAG Pharmaceuticals, Inc. (AMAG) AI Stock Price Forecast & Investment Analysis

AMAG Pharmaceuticals, Inc. Stock Price Chart and Technical Analysis

Loading AMAG Pharmaceuticals, Inc. interactive price chart and technical analysis...

AMAG Pharmaceuticals, Inc. (AMAG) - Comprehensive Stock Analysis & Investment Research

Deep dive into AMAG Pharmaceuticals, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about AMAG Pharmaceuticals, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For AMAG Pharmaceuticals, Inc.: AMAG Pharmaceuticals, Inc. operates in the Health Technology sector, making it an emerging small-cap investment.

AMAG Pharmaceuticals, Inc. (Stock Symbol: AMAG) is a leading company in the Health Technology sector , specifically operating within the Pharmaceuticals: Major industry.

The organization employs approximately 440 professionals worldwide and operates under the strategic leadership of CEO Scott D. Myers.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing AMAG Pharmaceuticals, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AMAG Pharmaceuticals, Inc.: With $301M in annual revenue and -76.5% net margin, the company demonstrates developing profitability.

Annual Revenue: $301 million generating a -76.5% net profit margin .

Market Capitalization: $468 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -62.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for AMAG Pharmaceuticals, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For AMAG Pharmaceuticals, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for AMAG Pharmaceuticals, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: AMAG Pharmaceuticals, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For AMAG Pharmaceuticals, Inc.: Market positioning analysis based on available financial and operational metrics.

AMAG Pharmaceuticals, Inc. strategically competes in the highly dynamic Pharmaceuticals: Major marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 67.2% gross margin, indicating strong pricing power and operational efficiency.

AMAG Pharmaceuticals, Inc. (AMAG) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for AMAG Pharmaceuticals, Inc. stock analysis.

Loading AMAG Pharmaceuticals, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into AMAG Pharmaceuticals, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if AMAG Pharmaceuticals, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For AMAG Pharmaceuticals, Inc.: With a P/E ratio of -2.03, the market sees the stock as potentially undervalued.

P/E Ratio -2.03x
P/B Ratio 1.87x
Market Cap $468M
EPS $-6.78
Book Value/Share $7.37
Revenue/Share $8.85
FCF/Share $-5.63
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently AMAG Pharmaceuticals, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AMAG Pharmaceuticals, Inc.: An ROE of -62.6% indicates room for improvement in shareholder value creation.

ROE -62.6%
ROA -27.1%
ROIC -31.2%
Gross Margin 67.2%
Operating Margin -12.4%
Net Margin -76.5%
EBT Margin -76.5%
Tax Rate 127.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess AMAG Pharmaceuticals, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For AMAG Pharmaceuticals, Inc.: A current ratio of 1.75 shows adequate liquidity.

Current Ratio 1.75x
Quick Ratio 1.46x
D/E Ratio 1.20x
Financial Leverage 2.87x
Interest Coverage -8.2x
Working Capital $108M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal AMAG Pharmaceuticals, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For AMAG Pharmaceuticals, Inc.: Free cash flow of $-28M indicates cash challenges that need attention.

Operating Cash Flow $-27M
Free Cash Flow $-28M
Capital Spending $-1M
OCF Growth YoY -43.7%
FCF Growth YoY 35.1%
FCF/Sales -9.2%
CapEx/Sales 0.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively AMAG Pharmaceuticals, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For AMAG Pharmaceuticals, Inc.: An asset turnover of 0.35x suggests room for improvement in asset utilization.

Asset Turnover 0.35x
Receivables Turnover 4.2x
Inventory Turnover 3.8x
Fixed Assets Turnover 15.9x
Days Sales Outstanding 88 days
Days Inventory 95 days
Payables Period 67 days
Cash Conversion Cycle 116 days
Understanding Financial Statement Data

What these metrics mean: Key figures from AMAG Pharmaceuticals, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For AMAG Pharmaceuticals, Inc.: With annual revenue of $301M, AMAG Pharmaceuticals, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $301M
Operating Income $-38M
Net Income $-230M
R&D Expense $14M
SG&A Expense $65M
Cost of Goods Sold $33M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 39%
Cash & Short-term Investments 23%
Total Liabilities 65%
Short-term Debt 2%
Accounts Receivable 9%
Inventory 3%
Dividend & Shareholder Information
Shares Outstanding 34M

Latest AMAG Pharmaceuticals, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting AMAG Pharmaceuticals, Inc. (AMAG) stock price and investment outlook.

, source: San Antonio Express-News

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So what: AMAG's ...

, source: Reuters

* Q2 earnings per share view $1.20, revenue view $128.5 million -- Thomson Reuters I/B/E/S * Fy2016 revenue view $533.8 million -- Thomson Reuters I/B/E/S * Total gaap quarterly product and service ...

, source: Nasdaq

AlloVir (ALVR) has provided an announcement. AlloVir, Inc. has finalized a deal with AMAG Pharmaceuticals, Inc. to terminate a sublease agreement for their Waltham, Massachusetts premises, effective ...

AMAG Pharmaceuticals, Inc. Competitors & Peer Analysis - Health Technology Sector

Comparative analysis of AMAG Pharmaceuticals, Inc. against industry peers and competitors in the Health Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - AMAG Pharmaceuticals, Inc. Stock Forecast

How accurate are AMAG Pharmaceuticals, Inc. stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for AMAG predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence AMAG Pharmaceuticals, Inc. stock price forecasts?

Our analysis considers AMAG Pharmaceuticals, Inc.'s financial metrics, Health Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is AMAG Pharmaceuticals, Inc. a good investment in 2025?

Based on our AI analysis, AMAG Pharmaceuticals, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are AMAG Pharmaceuticals, Inc. forecasts updated?

AMAG Pharmaceuticals, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced AMAG Pharmaceuticals, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for AMAG Pharmaceuticals, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...